PEPT-IN
DEAD

Serial Number

79293682

Owner

AELIN THERAPEUTICS N.V.

Attorney

Clifford D. Hyra

Filing Date

Jul 10, 2020

Add to watchlist:

No watchlists yet
View on USPTO

PEPT-IN Trademark

Serial Number: 79293682

PEPT-IN is a trademark filed by AELIN THERAPEUTICS N.V. on July 10, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

AELIN THERAPEUTICS N.V.

Gaston Geenslaan 1

Entity Type: 99

Trademark Details

Filing Date

July 10, 2020

Registration Date

Not Registered

Goods & Services

Pharmaceutical and veterinary products, namely, pharmaceutical products and medications made of peptides for inducing protein aggregation in the treatment of cancer and infectious diseases and synthetic peptides as pharmaceutical products and medications for inducing protein aggregation in the treatment of cancer and infectious diseases; all of the foregoing commercialized through a select network of clinicians who administer the products and medications in a hospital setting or available through prescription by a clinician

Scientific and technological services and research and design relating thereto, namely, pharmaceutical research and development of peptide-based pharmaceutical products and medicines and pharmaceutical research and development of pharmaceutical products and medicines on the basis of protein aggregation stimulating peptides

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 4, 2025 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Dec 16, 2024 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 16, 2024 FICR
ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Dec 15, 2023 MAB3
ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Dec 15, 2023 MAB3
ABANDONMENT - AFTER EX PARTE APPEAL
Dec 14, 2023 ABN3
EXPARTE APPEAL TERMINATED
Dec 14, 2023 EXPT
EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
Oct 30, 2023 EXFB
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Aug 16, 2023 GEA1
ACTION DENYING REQ FOR RECON E-MAILED
Aug 16, 2023 GECD
ACTION CONTINUING FINAL - COMPLETED
Aug 16, 2023 CNCF
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 18, 2022 RCCK
NEW REPRESENTATIVE AT IB RECEIVED
Apr 2, 2022 NREP
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 1, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 1, 2022 GNSL
SUSPENSION LETTER WRITTEN
Apr 1, 2022 CNSL
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 13, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 23, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 23, 2022 OPNR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 26, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 26, 2022 CRFA
ASSIGNED TO LIE
Jan 26, 2022 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 21, 2022 ERFR
EX PARTE APPEAL-INSTITUTED
Jan 20, 2022 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jan 20, 2022 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Jan 20, 2022 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 30, 2021 GNFN
FINAL REFUSAL E-MAILED
Jul 30, 2021 GNFR
FINAL REFUSAL WRITTEN
Jul 30, 2021 CNFR
ASSIGNED TO EXAMINER
Jul 4, 2021 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 26, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 26, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 26, 2021 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Apr 2, 2021 NREP
REFUSAL PROCESSED BY IB
Dec 6, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 13, 2020 RFCS
REFUSAL PROCESSED BY MPU
Nov 13, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 27, 2020 RFCR
NON-FINAL ACTION WRITTEN
Oct 26, 2020 CNRT
ASSIGNED TO EXAMINER
Oct 22, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 29, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 25, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 22, 2020 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 17, 2020 REPR